Efferocytosis: The Janus‐Faced Gatekeeper of Aging and Tumor Fate
Aging Cell · 2025-02 · 24 (2)
DOI: 10.1111/acel.14467 ↗Kurz gefasst
Übersichtsarbeit in der Zeitschrift Aging Cell, online erschienen am 03.01.2025. Verfasst von Zaoqu Liu und 14 weiteren Autor:innen. Beteiligte Einrichtung: Department of Interventional Radiology, The First Affiliated Hospital of Zhengzhou University, Zhengzhou, Henan, China. Hauptthemen laut MEDLINE: Neoplasms, Aging, Phagocytosis. Die Arbeit wurde bisher 22-mal zitiert (Crossref) und nennt 184 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Major Science and Technology Projects of Henan Province.
Abstract (Originalsprache)
From embryogenesis to aging, billions of cells perish daily in mammals. The multistep process by which phagocytes engulf these deceased cells without eliciting an inflammatory response is called efferocytosis. Despite significant insights into the fundamental mechanisms of efferocytosis, its implications in disorders such as aging and cancer remain elusive. Upon summarizing and analyzing existing studies on efferocytosis, it becomes evident that efferocytosis is our friend in resolving inflammation, yet it transforms into our foe by facilitating tumor development and metastasis. This review illuminates recent discoveries regarding the emerging mechanisms of efferocytosis in clearing apoptotic cells, explores its connections with aging, examines its influence on tumor development and metastasis, and identifies the regulatory factors of efferocytosis within the tumor microenvironment. A comprehensive understanding of these efferocytosis facets offers insights into crucial physiological and pathophysiological processes, paving the way for innovative therapeutic approaches to combat aging and cancer.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Department of Interventional Radiology, The First Affiliated Hospital of Zhengzhou University, Zhengzhou, Henan, China.
- Interventional Institute of Zhengzhou University, Zhengzhou, Henan, China.
- Interventional Treatment and Clinical Research Center of Henan Province, Zhengzhou, Henan, China.
- Institute of Basic Medical Sciences, Chinese Academy of Medical Sciences and Peking Union Medical College, Beijing, China.
- Medical School of Zhengzhou University, Zhengzhou, Henan, China.
- Department of Respiratory and Critical Care Medicine, The First Affiliated Hospital of Zhengzhou University, Zhengzhou, Henan, China.
ORCID-Profile: Zaoqu Liu, Quan Chen, Xinwei Han
Förderung
- Major Science and Technology Projects of Henan Province
Zitieren
APA
Liu, Z., Li, Y., Ren, Y., Chen, J., Weng, S., Zhou, Z., Luo, P., Chen, Q., Xu, H., Ba, Y., Zuo, A., Liu, S., Zhang, Y., Pan, T., & Han, X. (2025). Efferocytosis: The Janus‐Faced Gatekeeper of Aging and Tumor Fate. Aging Cell, 24(2). https://doi.org/10.1111/acel.14467
Vancouver
Liu Z, Li Y, Ren Y, Chen J, Weng S, Zhou Z, et al. Efferocytosis: The Janus‐Faced Gatekeeper of Aging and Tumor Fate. Aging Cell. 2025;24(2). doi:10.1111/acel.14467
BibTeX
@article{Liu2025,
author = {Liu, Zaoqu and Li, Yan and Ren, Yuqing and Chen, Jingqi and Weng, Siyuan and Zhou, Zhaokai and Luo, Peng and Chen, Quan and Xu, Hui and Ba, Yuhao and Zuo, Anning and Liu, Shutong and Zhang, Yuyuan and Pan, Teng and Han, Xinwei},
title = {Efferocytosis: The Janus‐Faced Gatekeeper of Aging and Tumor Fate},
journal = {Aging Cell},
year = {2025},
volume = {24},
number = {2},
doi = {10.1111/acel.14467}
}
EUVIMED